Kir2.1 Explained

The Kir2.1 inward-rectifier potassium channel is a lipid-gated ion channel encoded by the gene.[1] [2] [3] [4]

Clinical significance

A defect in this gene is associated with Andersen-Tawil syndrome.[5]

A mutation in the KCNJ2 gene has also been shown to cause short QT syndrome.[6]

In research

In neurogenetics, Kir2.1 is used in Drosophila research to inhibit neurons, as overexpression of this channel will hyperpolarize cells.

In optogenetics, a trafficking sequence from Kir2.1 has been added to halorhodopsin to improve its membrane localization. The resulting protein eNpHR3.0 is used in optogenetic research to inhibit neurons with light.[7]

Expression of Kir2.1 gene in human HEK293 cells induce a transient outward current, creating a steady membrane potential close to the reversal potential of potassium.[8]

Interactions

Kir2.1 has been shown to interact with:

Further reading

External links

Notes and References

  1. Hansen . SB . Lipid agonism: The PIP2 paradigm of ligand-gated ion channels. . Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids . May 2015 . 1851 . 5 . 620–8 . 10.1016/j.bbalip.2015.01.011 . 25633344. 4540326 .
  2. Raab-Graham KF, Radeke CM, Vandenberg CA . Molecular cloning and expression of a human heart inward rectifier potassium channel . NeuroReport . 5 . 18 . 2501–5 . 1994 . 7696590 . 10.1097/00001756-199412000-00024 .
  3. Derst C, Karschin C, Wischmeyer E, Hirsch JR, Preisig-Müller R, Rajan S, Engel H, Grzeschik K, Daut J, Karschin A . Genetic and functional linkage of Kir5.1 and Kir2.1 channel subunits . FEBS Lett. . 491 . 3 . 305–11 . 2001 . 11240146 . 10.1016/S0014-5793(01)02202-5 . 14452157 . 2001FEBSL.491..305D .
  4. Kubo Y, Adelman JP, Clapham DE, Jan LY, Karschin A, Kurachi Y, Lazdunski M, Nichols CG, Seino S, Vandenberg CA . International Union of Pharmacology. LIV. Nomenclature and molecular relationships of inwardly rectifying potassium channels . Pharmacol. Rev. . 57 . 4 . 509–26 . 2005 . 16382105 . 10.1124/pr.57.4.11 . 11588492 .
  5. Donaldson MR, Yoon G, Fu YH, Ptacek LJ . Andersen-Tawil syndrome: a model of clinical variability, pleiotropy, and genetic heterogeneity . Ann. Med. . 36 . 92–7 . 2004 . Suppl 1 . 15176430 . 10.1080/17431380410032490 . 7362563 .
  6. Priori SG, Pandit SV, Rivolta I, Berenfeld O, Ronchetti E, Dhamoon A, Napolitano C, Anumonwo J, di Barletta MR, Gudapakkam S, Bosi G, Stramba-Badiale M, Jalife J . A novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene . Circ. Res. . 96 . 7 . 800–7 . April 2005 . 15761194 . 10.1161/01.RES.0000162101.76263.8c . free .
  7. Gradinaru V, Zhang F, Ramakrishnan C, Mattis J, Prakash R, Diester I, Goshen I, Thompson KR, Deisseroth K . Molecular and cellular approaches for diversifying and extending optogenetics . Cell . 141 . 1 . 154–65 . April 2010 . 20303157 . 4160532 . 10.1016/j.cell.2010.02.037 .
  8. Zhang. De-Yong. Lau. Chu-Pak. Li. Gui-Rong. 2009-04-01. Human Kir2.1 channel carries a transient outward potassium current with inward rectification. Pflügers Archiv: European Journal of Physiology. 457. 6. 1275–1285. 10.1007/s00424-008-0608-0. 1432-2013. 19002489. 3120804.
  9. Nehring RB, Wischmeyer E, Döring F, Veh RW, Sheng M, Karschin A . Neuronal inwardly rectifying K(+) channels differentially couple to PDZ proteins of the PSD-95/SAP90 family . J. Neurosci. . 20 . 1 . 156–62 . 2000 . 10627592 . 6774109 . 10.1523/JNEUROSCI.20-01-00156.2000.
  10. Kurschner C, Yuzaki M . Neuronal interleukin-16 (NIL-16): a dual function PDZ domain protein . J. Neurosci. . 19 . 18 . 7770–80 . 1999 . 10479680 . 6782450 . 10.1523/JNEUROSCI.19-18-07770.1999.
  11. Grishin A, Li H, Levitan ES, Zaks-Makhina E . Identification of gamma-aminobutyric acid receptor-interacting factor 1 (TRAK2) as a trafficking factor for the K+ channel Kir2.1 . J. Biol. Chem. . 281 . 40 . 30104–11 . 2006 . 16895905 . 10.1074/jbc.M602439200 . free .